Insights into JAK2-V617F mutation in CML

Lancet Oncol. 2007 Oct;8(10):863-4. doi: 10.1016/S1470-2045(07)70294-2.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Fusion Proteins, bcr-abl / genetics
  • Humans
  • Janus Kinase 2 / genetics*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Mutation*

Substances

  • Fusion Proteins, bcr-abl
  • JAK2 protein, human
  • Janus Kinase 2